2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--II. Biochemical properties

Neuropharmacology. 1985 Nov;24(11):1085-92. doi: 10.1016/0028-3908(85)90196-0.


Two models have been chosen to study the effect of 2-amino-6-trifluoromethoxy benzothiazole (PK 26124) on excitatory amino acid neurotransmission: the pool of cyclic guanosine monophosphate (cGMP) in the cerebellum and the release of acetylcholine in the striatum and olfactory tubercles. The release of acetylcholine induced by N-methyl-DL-aspartate in the striatum and olfactory tubercles was antagonized by PK 26124 which was less potent on the release of acetylcholine induced electrically. The increase in levels of cGMP in the cerebellum induced by excitatory amino acids such as glutamate and quisqualate was antagonized by PK 26124, but the drug was inactive against N-methyl-DL-aspartate, L-aspartate, kainate and cysteine sulphinate. In vivo it antagonized the increases of cGMP in the cerebellum elicited by all these excitatory compounds. All these results are compatible with a possible antagonism by PK 26124 of the excitatory amino acid neurotransmission and may explain its anticonvulsant properties.

MeSH terms

  • Acetylcholine / metabolism
  • Amino Acids / physiology*
  • Animals
  • Anticonvulsants
  • Apomorphine / pharmacology
  • Cerebellum / metabolism
  • Chlordiazepoxide / pharmacology
  • Cyclic GMP / metabolism
  • Diazepam / pharmacology
  • Harmaline / pharmacology
  • In Vitro Techniques
  • Injections, Intraventricular
  • Isoniazid / pharmacology
  • Male
  • Rats
  • Rats, Inbred Strains
  • Riluzole
  • Synaptic Transmission / drug effects*
  • Thiazoles / pharmacology*
  • gamma-Aminobutyric Acid / metabolism


  • Amino Acids
  • Anticonvulsants
  • Thiazoles
  • gamma-Aminobutyric Acid
  • Chlordiazepoxide
  • Riluzole
  • Harmaline
  • Cyclic GMP
  • Apomorphine
  • Acetylcholine
  • Diazepam
  • Isoniazid